At close: 4:00:02 PM EST
After hours: 6:08:12 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 4 | 4 |
| Avg. Estimate | 0.04 | 0.08 | 0.29 | 0.47 |
| Low Estimate | -0.03 | 0.04 | 0.23 | 0.42 |
| High Estimate | 0.12 | 0.11 | 0.37 | 0.55 |
| Year Ago EPS | 0.11 | 0.06 | 0.2 | 0.29 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 6 | 6 |
| Avg. Estimate | 100.82M | 104.62M | 392.02M | 430.23M |
| Low Estimate | 97.8M | 99.2M | 389M | 419.6M |
| High Estimate | 102.4M | 107.1M | 393.6M | 436M |
| Year Ago Sales | 93.67M | 97.43M | 354M | 392.02M |
| Sales Growth (year/est) | 7.63% | 7.38% | 10.74% | 9.75% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0 | 0.02 | 0.03 | 0.01 |
| EPS Actual | 0.11 | 0.06 | 0.07 | 0.12 |
| Difference | 0.11 | 0.04 | 0.04 | 0.11 |
| Surprise % | 0.00% | 157.18% | 162.47% | 1,100.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.04 | 0.08 | 0.29 | 0.47 |
| 7 Days Ago | 0.04 | 0.08 | 0.29 | 0.47 |
| 30 Days Ago | 0.04 | 0.08 | 0.29 | 0.47 |
| 60 Days Ago | 0.05 | 0.09 | 0.2 | 0.5 |
| 90 Days Ago | 0.05 | 0.09 | 0.2 | 0.5 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AORT | -65.91% | 33.33% | 45.00% | 63.79% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 12/10/2024 |
| Reiterates | Needham: Buy to Buy | 12/9/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 11/8/2024 |
| Initiated | JMP Securities: Market Outperform | 10/23/2024 |
| Reiterates | Needham: Buy to Buy | 9/27/2024 |
| Maintains | Stifel: Buy to Buy | 9/13/2024 |
Related Tickers
AXGN Axogen, Inc.
14.86
+0.13%
SIBN SI-BONE, Inc.
13.83
-2.61%
LIVN LivaNova PLC
51.49
+2.90%
CNMD CONMED Corporation
73.32
-1.90%
IRTC iRhythm Technologies, Inc.
89.93
+3.49%
TMCI Treace Medical Concepts, Inc.
7.83
-0.89%
MXCT MaxCyte, Inc.
4.4300
+5.73%
BRKR Bruker Corporation
59.65
-0.55%
ELUT Elutia Inc.
4.0100
-6.74%
ITGR Integer Holdings Corporation
140.62
+0.70%